alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › targeting-tau

targeting-tau

3 studies tagged targeting-tau, dated 2013-03-01 to 2024-02-28. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Korean red ginseng polysaccharide as a potential therapeutic agent targeting tau pathology in Alzheimer's disease 2024-02-28
  2. Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease 2015-08-01
  3. Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathies 2013-03-01

Studies

3 studies carry this tag.

Date range

2013 to 2024

Top journals

  • Current Alzheimer research 1
  • Expert opinion on investigational drugs 1
  • International journal of biological macromolecules 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Korean red ginseng polysaccharide as a potential therapeutic agent targeting tau pathology in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. International journal of biological macromolecules 2024-02-28 Drug development

    Tau is a microtubule-associated protein that plays a critical role in the stabilization and modulation of neuronal axons.

  2. Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Expert opinion on investigational drugs 2015-08-01 Drug development

    Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is a significant burden to society.

  3. Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathies

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Current Alzheimer research 2013-03-01 Drug development

    The drawbacks of amyloid immunotherapy, including the development of encephalitis, the lack of clinical improvement and of any effect on neurofibrillary tangles (NFTs), coupled with the central role of NFTs in dementia, may point that clearance of amyloid pathology is not sufficient for improving the dementia symptoms in Alzheimer's disease (AD) patients.

All topic tags with their study counts